Eli Lilly Expands Domestic Drug Production as Investors Reassess Valuations

New York, Sunday, 15 November 2026.
Eli Lilly broke ground on a $3.5 billion Pennsylvania manufacturing site as its valuation touched $1.28 trillion, highlighting investor focus on tangible production amid shifting market sentiment.